Chemical Industry Shionogi Fortifies Rare Disease Strategy with Multibillion-Dollar Acquisition of IntraBio and Flagship Drug Aqneursa TOKYO & NEW JERSEY — In a major strategic maneuver that underscores its aggressive pivot… Siti MuinahOctober 6, 2026
